Annual FCF
-$51.66 M
+$52.14 M+50.23%
31 December 2023
Summary:
Relmada Therapeutics annual free cash flow is currently -$51.66 million, with the most recent change of +$52.14 million (+50.23%) on 31 December 2023. During the last 3 years, it has fallen by -$23.85 million (-85.77%). RLMD annual FCF is now -679626.32% below its all-time high of -$7600.00, reached on 31 August 2012.RLMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$16.66 M
-$3.39 M-25.59%
30 September 2024
Summary:
Relmada Therapeutics quarterly free cash flow is currently -$16.66 million, with the most recent change of -$3.39 million (-25.59%) on 30 September 2024. Over the past year, it has dropped by -$5.03 million (-43.21%). RLMD quarterly FCF is now -1110526.67% below its all-time high of $1500.00, reached on 30 November 2012.RLMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$53.21 M
-$5.03 M-10.43%
30 September 2024
Summary:
Relmada Therapeutics TTM free cash flow is currently -$53.21 million, with the most recent change of -$5.03 million (-10.43%) on 30 September 2024. Over the past year, it has increased by +$24.09 million (+31.16%). RLMD TTM FCF is now -3547153.33% below its all-time high of $1500.00, reached on 30 November 2012.RLMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.2% | -43.2% | +31.2% |
| 3 y3 years | -85.8% | +20.4% | +13.0% |
| 5 y5 years | -705.4% | -557.3% | -368.3% |
RLMD Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -85.8% | +50.2% | -62.5% | +55.8% | -10.4% | +49.6% |
| 5 y | 5 years | -705.4% | +50.2% | -557.3% | +55.8% | -452.7% | +49.6% |
| alltime | all time | <-9999.0% | +50.2% | <-9999.0% | +55.8% | <-9999.0% | +49.6% |
Relmada Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.66 M(+25.6%) | -$53.21 M(+10.4%) |
| June 2024 | - | -$13.26 M(+1.7%) | -$48.18 M(-0.0%) |
| Mar 2024 | - | -$13.04 M(+27.2%) | -$48.19 M(-6.7%) |
| Dec 2023 | -$51.66 M(-50.2%) | -$10.25 M(-11.9%) | -$51.66 M(-33.2%) |
| Sept 2023 | - | -$11.63 M(-12.4%) | -$77.29 M(-16.5%) |
| June 2023 | - | -$13.27 M(-19.6%) | -$92.52 M(-8.3%) |
| Mar 2023 | - | -$16.51 M(-54.0%) | -$100.88 M(-2.8%) |
| Dec 2022 | -$103.80 M(+13.0%) | -$35.88 M(+33.6%) | -$103.80 M(-1.7%) |
| Sept 2022 | - | -$26.86 M(+24.2%) | -$105.58 M(+6.0%) |
| June 2022 | - | -$21.63 M(+11.3%) | -$99.63 M(+4.6%) |
| Mar 2022 | - | -$19.43 M(-48.4%) | -$95.22 M(+3.6%) |
| Dec 2021 | -$91.87 M(+230.4%) | -$37.66 M(+80.1%) | -$91.87 M(+50.3%) |
| Sept 2021 | - | -$20.92 M(+21.5%) | -$61.14 M(+16.0%) |
| June 2021 | - | -$17.21 M(+7.0%) | -$52.73 M(+30.3%) |
| Mar 2021 | - | -$16.09 M(+132.2%) | -$40.47 M(+45.5%) |
| Dec 2020 | -$27.81 M(+333.6%) | -$6.93 M(-44.6%) | -$27.81 M(+33.2%) |
| Sept 2020 | - | -$12.50 M(+152.4%) | -$20.88 M(+91.3%) |
| June 2020 | - | -$4.95 M(+44.6%) | -$10.91 M(+13.4%) |
| Mar 2020 | - | -$3.42 M(+35.1%) | -$9.63 M(-15.3%) |
| Dec 2019 | -$6.41 M(-38.9%) | - | - |
| Sept 2019 | - | -$2.53 M(-30.9%) | -$11.36 M(+8.2%) |
| June 2019 | -$10.50 M | -$3.67 M(+82.3%) | -$10.50 M(+15.3%) |
| Mar 2019 | - | -$2.01 M(-36.1%) | -$9.11 M(+4.4%) |
| Dec 2018 | - | -$3.15 M(+88.4%) | -$8.72 M(+30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$1.67 M(-26.6%) | -$6.70 M(+11.5%) |
| June 2018 | -$6.01 M(-7.7%) | -$2.28 M(+40.0%) | -$6.01 M(+26.4%) |
| Mar 2018 | - | -$1.63 M(+43.6%) | -$4.76 M(-5.0%) |
| Dec 2017 | - | -$1.13 M(+15.3%) | -$5.01 M(-6.0%) |
| Sept 2017 | - | -$981.60 K(-3.6%) | -$5.33 M(-18.2%) |
| June 2017 | -$6.52 M(-52.5%) | -$1.02 M(-45.7%) | -$6.52 M(-21.9%) |
| Mar 2017 | - | -$1.88 M(+29.1%) | -$8.35 M(-17.9%) |
| Dec 2016 | - | -$1.45 M(-33.0%) | -$10.16 M(-19.7%) |
| Sept 2016 | - | -$2.17 M(-23.8%) | -$12.66 M(-7.6%) |
| June 2016 | -$13.71 M(-15.7%) | -$2.85 M(-22.8%) | -$13.71 M(-10.7%) |
| Mar 2016 | - | -$3.69 M(-6.6%) | -$15.35 M(-4.6%) |
| Dec 2015 | - | -$3.95 M(+22.8%) | -$16.09 M(-6.1%) |
| Sept 2015 | - | -$3.22 M(-28.4%) | -$17.13 M(+5.4%) |
| June 2015 | -$16.25 M(+649.6%) | -$4.49 M(+1.3%) | -$16.25 M(+38.2%) |
| Mar 2015 | - | -$4.43 M(-11.1%) | -$11.76 M(+60.5%) |
| Dec 2014 | - | -$4.99 M(+113.9%) | -$7.33 M(+212.4%) |
| Sept 2014 | - | -$2.33 M(>+9900.0%) | -$2.35 M(+9357.3%) |
| June 2014 | -$2.17 M(>+9900.0%) | - | - |
| Feb 2014 | - | -$3500.00(-61.5%) | -$24.80 K(+2.5%) |
| Nov 2013 | - | -$9100.00(+68.5%) | -$24.20 K(+77.9%) |
| Aug 2013 | -$13.70 K(+80.3%) | -$5400.00(-20.6%) | -$13.60 K(+65.9%) |
| May 2013 | - | -$6800.00(+134.5%) | -$8200.00(+485.7%) |
| Feb 2013 | - | -$2900.00(-293.3%) | -$1400.00(-193.3%) |
| Nov 2012 | - | $1500.00 | $1500.00 |
| Aug 2012 | -$7600.00 | - | - |
FAQ
- What is Relmada Therapeutics annual free cash flow?
- What is the all time high annual FCF for Relmada Therapeutics?
- What is Relmada Therapeutics annual FCF year-on-year change?
- What is Relmada Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly FCF year-on-year change?
- What is Relmada Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Relmada Therapeutics?
- What is Relmada Therapeutics TTM FCF year-on-year change?
What is Relmada Therapeutics annual free cash flow?
The current annual FCF of RLMD is -$51.66 M
What is the all time high annual FCF for Relmada Therapeutics?
Relmada Therapeutics all-time high annual free cash flow is -$7600.00
What is Relmada Therapeutics annual FCF year-on-year change?
Over the past year, RLMD annual free cash flow has changed by +$52.14 M (+50.23%)
What is Relmada Therapeutics quarterly free cash flow?
The current quarterly FCF of RLMD is -$16.66 M
What is the all time high quarterly FCF for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly free cash flow is $1500.00
What is Relmada Therapeutics quarterly FCF year-on-year change?
Over the past year, RLMD quarterly free cash flow has changed by -$5.03 M (-43.21%)
What is Relmada Therapeutics TTM free cash flow?
The current TTM FCF of RLMD is -$53.21 M
What is the all time high TTM FCF for Relmada Therapeutics?
Relmada Therapeutics all-time high TTM free cash flow is $1500.00
What is Relmada Therapeutics TTM FCF year-on-year change?
Over the past year, RLMD TTM free cash flow has changed by +$24.09 M (+31.16%)